DMIIR

Drugs Made In America Acquisiti

52W High Breakout

$0.09+$0.00 (+3.53%)

Loading Chart...

Institutional Signal // Day Trade Edge:Neutral / No Active Setup Today

Scan Active Universe on Day Trade Edge

Key Statistics

Market Cap—

Forward P/E—

EPS (TTM)—

52-Week Return—

50-Day Moving Avg—

200-Day Moving Avg—

Volume Today2.72K

Avg Volume2.72K

Day Range$0.09 – $0.09

52-Week Range$0.09 – $0.09

Open Price$0.07

Previous Close$0.09

Company Profile

Description

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

CEO

Mr. Roger Bendelac

SEC Filings

EDGAR Filings

Exchange Listing

Nasdaq.com